Can Cholesterol Lowering Drugs Influence Circulating Omega-3 Fatty Acid Levels
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine if the administration of a cholesterol lowering
drug like ezetimibe will reduce circulating omega-3 fatty acid (ALA) levels in patients with
heart disease and hypercholesterolemia.
The investigators hypothesize that their data will discover that patients receiving ezetimibe
require additional dietary supplementation with omega-3 supplements to insure that these
beneficial fatty acids are available to these patients.